Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...

GSK has reported promising results with a drug to treat the severe itching that plagues patients with rare cholestatic liver disease primary biliary cholangitis (PBC). Interim results from the ...

Mirum Pharmaceuticals, Inc. today announced that its partner, Takeda Pharmaceutical Company Limited, has received approval by the Japanese Ministry of Health, Labour, and Welfare for LIVMARLI® ...

"VS-01 has the potential to be the first drug to use the intraperitoneal route to simultaneously support the liver, kidney ... also in trials for PBC – which included a €120 million upfront ...

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment. Treatment of this autoimmune liver disease should also address various symptoms and complications ...

“Studies show that an integrated program of pharmacologic and mental health is most effective in healing a patient’s liver ...

Fatty liver disease occurs when excess fat gets deposited in the liver due to reasons other than alcohol. (Image Credits: Pixabay) Fatty liver disease, medically known as hepatic steatosis ...

Irene Wells didn't ask just how bad her pancreatic cancer was — she just wanted aggressive treatment so she could do "a ...

Eating a healthy plant-based diet that includes vegetables, tea, and coffee may help people with cardiometabolic ...